baber/WOPTO huggingface dataset:
Patent FI-943431-A0 (FI)
Inventor: LINDSTROEM LARS-AOKE
IPC: D21C9/147
Filed: 1994-07-20
Abstract: A method of bleaching sulphate pulp without using chlorine-containing bleaching agents. The sulphate pulp is oxygen delignified and can possibly also be ozone delignified to a kappa number below 9.5. Thereafter a pretreatment with complexing agent is carried out for 1-60 minutes, at which the pulp consistency is 1-15 %, the temperature 70-110  DEG C and pH 5-7. The pulp thus pretreated is washed and dewatered to a consistency of 18-40 %. Thereafter peroxide bleaching in alkaline environment takes place in the presence of silicate or an organic complexing agent of the type phosphonic or carboxylic acid.
Patent FI-952383-A0 (FI)
Inventor: SCHUSTER INGEBORG
IPC: C07D233/54
Filed: 1995-05-16
Abstract: The invention concerns azole compounds of formula <CHEM> wherein the substituents have various significances, in free form or salt form. They can be prepared e.g. by acylation, or by aziridine or oxazole ring opening. The compounds can be used as pharmaceuticals, especially as selective inhibitors of the 25-hydroxyvitamin D3 - hydroxylases in the treatment of disorders of proliferation and differentiation in vitamin D - responsive tissues.
Patent FI-953071-A0 (FI)
Inventor: GAIER WALTER
IPC: A23K50/48
Filed: 1995-06-21
Abstract: A fermented animal food is prepd. by (a) pasteurising, with continuous homogenisation, a finely divided and emulsified mixt. of (i) a collagenic material, (ii) a protein material, and (iii) milk, and (b) fermenting with lactic bacteria.
Patent FI-954855-A0 (FI)
Inventor: BERTINA ROGIER MARIA
IPC: C12Q1/6883
Filed: 1995-10-12
Abstract: Method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C (APC). The method is directed at detecting one or more mutations at one or more of the cleavage and/or binding sites for APC of Factor V and/or Factor Va or at Factor VIII and/or Factor VIIIa at either nucleic acid or protein level or both.
Patent FI-955326-A0 (FI)
Inventor: HAARTSEN JACOBUS CORNELIS
IPC: H04B7/005
Filed: 1995-11-06
Abstract: A method and system for the adaptive allocation of channels within a radiocommunication system, specifically a cellular network, is presented. The allocation method takes advantage of measurements made by the mobile radiotelephone and allocates channels based on the carrier to interference ratio. Using adaptive power control, consideration is given to maintaining an acceptable carrier to interference ratio while at the same time minimizing transmit power. Exemplary embodiments consider independent allocation of the uplink and downlink as well as independent determination of the uplink and downlink power levels. Other exemplary embodiments also give consideration to an efficient method for slot allocation in a TDMA communication system. <IMAGE>
Patent FI-963266-A0 (FI)
Inventor: SVENDSEN ALLAN
IPC: C12N15/09
Filed: 1996-08-21
Abstract: The present invention relates to a method of preparing a variant of a parent lipolytic enzyme, comprising (a) subjecting a DNA sequence encoding the parent lipolytic enzyme to random mutagenesis, (b) expressing the mutated DNA sequence obtained in step (a) in a host cell, and (c) screening for host cells expressing a mutated lipolytic enzyme which has a decreased dependance to calcium and/or an improved tolerance towards a detergent or a detergent component as compared to the parent lipolytic enzyme.
Patent FI-972774-A0 (FI)
Inventor: MAONSSON LARS HAAHR
IPC: A47G27/02
Filed: 1997-06-27
Abstract: PCT No. PCT/DK95/00523 Sec. 371 Date Jun. 20, 1997 Sec. 102(e) Date Jun. 20, 1997 PCT Filed Dec. 28, 1995 PCT Pub. No. WO96/20627 PCT Pub. Date Jul. 11, 1996A resilient mat upon which people can walk or stand includes a pattern of punctiformed portions extending upwardly from an upper side of the mat and a pattern of punctiformed portions extending downwardly from an underside of the mat (to contact an underlying support surface), the upwardly- and downwardly-extending portions being offset from one another so that the upwardly-extending, punctiformed portions will move resiliently downwardly in a direction between downwardly-extending punctiformed portions when subjected to downward force from the foot of a person thereon.
Patent FI-982849-A0 (FI)
IPC: B01D53/02
Filed: 1998-12-31
Abstract: The present invention is a process for ammonia gas separation from gas mixtures by a solid copper (I)-containing adsorbent. The process enables an effective and selective separation of ammonia gas from gas mixtures. Additionally it enables the efficient release of adsorbed ammonia by regeneration as well as the ammonia recovery as a pure gas for reuse. The present invention also comprises the adsorbent composition for use in selective adsorption of ammonia and the manufacturing of the adsorbent.
Patent IL-64419-A0 (IL)
Title: Diazotype materials and a diazotype printing process using the same
IPC: G03C1/61
Filed: 1981-12-01
Abstract: PCT No. PCT/FR81/00151 Sec. 371 Date Jul. 30, 1982 Sec. 102(e) Date Jul. 30, 1982 PCT Filed Nov. 19, 1981 PCT Pub. No. WO82/01944 PCT Pub. Date Jun. 10, 1982.The invention relates to new diazotype materials of which the sensitive layer contains, as a base generator, a compound comprising a basic part and an acid part, the acid part being a 2-carboxycarboxamide group and the basic part consisting of an alkali metal cation or alkaline earth metal cation or a tetraalkylammonium cation. These diazotype materials develop rapidly and possess an excellent resistance to ageing.
Patent IL-65354-A0 (IL)
Title: Triazole derivatives,their preparation and their use as microbicides
IPC: A01N43/653
Filed: 1982-03-25
Abstract: A compound selected from the group consisting of a 2 min -amino-2 min -phenyl-ethyl-1H-1,2,4-triazole of the formula (I) <CHEM> and the phytopharmaceutically acceptable salts and metal complexes thereof, wherein: R1 is a member selected from the group consisting of hydrogen, halo, C1-C4-alkyl, C1-C4-alkyloxy, and C1-C2-haloalkyl; R2 is a member selected from the group consisting of hydrogen, halo, C1-C4-alkyl, C1-C4-alkyloxy, C1-C2-haloalkyl and phenyl; R3 is a member selected from the group consisting of hydrogen, C1-C12-alkyl, C3-C8-cycloalkyl which is optionally substituted with C1-C4-alkyl, and aralkyl with maximum 2 carbon atoms in the alkyl part and optionally substituted on the phenyl nucleus with halo or nitro; R4 is a member selected from the group consisting of hydrogen and C1-C4-alkyl; whereby R3 and R4 may, together with the nitrogen atom to which they are attached, form a 3- to 7-membered saturated heterocyclic ring which may optionally be interrupted by oxygen, sulfur or NR5 and optionally substituted with R6, wherein R5 and R6 are each independently C1-C4-alkyl, a method of combating microorganisms by the use of such compounds, microbicidal agents comprising such compounds as active ingredients, processes of preparing the subject compounds and intermediates used therefore.
Patent IL-65524-A0 (IL)
Title: Ruminant lactation improvement
IPC: A23K20/195
Filed: 1982-04-19
Abstract: Glycopeptide antibiotics improve milk production in lactating ruminants when administered orally to the ruminants in a propionate-increasing amount.
Patent IL-70414-A0 (IL)
Title: Gene or sub-unit thereof and transfer vector comprising one of them,their preparation and their use for preparing human relaxin
IPC: C12P21/02
Filed: 1983-12-09
Abstract: Human H2-relaxin analogues are disclosed with modifications in the A and/or B peptide chains, as well as processes of preparing human H2-relaxin and analogues thereof.
Patent IL-75839-A0 (IL)
Title: Brass alloy,work materials and semi-processed products from said alloy and methods for their production
IPC: C22F1/08
Filed: 1985-07-18
Abstract: A brass alloy, a process for the production of a brass material or semi-finished brass product from that type of a brass alloy, as well as to the utilization of the brass material; in essence, the brass alloy for semi-finished products and semi-finished articles, which in addition to a good workability must possess a high resistance to wear, especially when employed for synchronous rings. The foregoing is possible through the intermediary of entirely determined contents of chromium and/or zircon in the previously described brass alloy. The chromium contents hereby vary, on the one hand, in dependence upon the silicon contents, and on the other hand, however, also to a lesser measure upon the remaining alloy components within the range of between 0.01 to 0.15% by weight, and preferably between 0.05 and 0.1% by weight.
Patent IL-76029-A0 (IL)
Title: Process for preparing antibiotic l 17046
IPC: C07K14/41
Filed: 1985-08-06
Abstract: This invention relates to a process for converting a teicoplanin-like compound into antibiotic L 17046 characterized in that a teicoplanin-like compound selected from teicoplanin complex, any further purified preparation thereof, teicoplanin factor A<sub>2'</sub> teicoplanin factor A<sub>3'</sub> each of the main components of teicoplanin factor A<sub>2</sub>, antibiotic L 17054 and a mixture of two or more of the above substances in any proportion is submitted to hydrolysis with a strong acid in the presence of a polar aprotic organic solvent selected from ethers, ketones and mixtures thereof that a room temperature are liquid.
Patent IL-98394-A0 (IL)
Title: Ws7622a mono or di-sulfate,salts thereof,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07K14/00
Filed: 1991-06-06
Abstract: Mono- or di-sulfate of the compound WS7622A, which is obtainable by culturing Streptomyces resistomycificus No. 7622 (FERM BP-2306), processes for preparation such sulfates and pharmaceutical compositions comprising them or their pharmaceutically acceptable salts as an active ingredient. <IMAGE>
Patent FI-20040090-A0 (FI)
Inventor: AULANKO ESKO
IPC: B66B23/22
Filed: 2004-01-22
Abstract: An apparatus for transporting passengers in a transport direction such as, for example, a travelator, moving ramp, or escalator, is provided. The apparatus includes a conveyor mounted on a first frame adapted to be supported on a fixed structure. The first frame includes two elongated first frame parts which include guide tracks for guiding the conveyor. The first frame parts may be profiled metallic bodies of solid material joined together end to end one after the other. The profiled metallic bodies include one or more extruded profiles. A handrail is provided and includes a handrail frame and an endless handrail belt mounted on the handrail frame. The endless handrail belt is arranged as a loop having an upper handhold portion that a passenger can grip with a hand for support and a lower return portion disposed inside the first frame. A number of suspenders are fastened to the first frame at a distance from each other to support the return portion of the handrail belt inside the profiled metallic bodies.
Patent FI-20045216-A0 (FI)
Inventor: LAURILA RISTO
IPC: H05K7/20
Filed: 2004-06-11
Abstract: The present invention relates to a cooling element (1) of an electronic device, comprising: an inlet opening (2), and outlet opening (3), and a flow channel (4, 5, 6, 7, 8). To achieve efficient cooling with as low costs as possible, the flow channel (7) is designed to cause a pressure difference between the forward end (4) and tail end (6) of the flow channel. At the higher-pressure forward end (4), an inlet opening (10) is arranged for a secondary cycle (11). At the lower-pressure tail end (6) of the cooling element (1) flow channel, an outlet opening (12) is arranged for said secondary cycle (11).
Patent IL-125088-A0 (IL)
Title: Modulation of TH1/TH2 cytokine expression
IPC: C07H19/16
Filed: 1997-01-21
Abstract: Ribavirin3 is administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin3 is used to suppress Th2-mediated T cell responses and promote Th1-mediated T cell response. In other aspects of the invention, one or more Ribavirin3 analogs are administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. The Ribavirin3 analog(s) may be used to suppress or enhance Th1 or Th2-mediated T cell responses.
Patent IL-128028-A0 (IL)
Title: Treatment of psychotic disorders
IPC: A61K31/4535
Filed: 1997-07-25
Abstract: The present invention relates to a method for the treatment of psychotic disorders.
Patent IL-139112-A0 (IL)
Title: Improvements in or relating to diagnostic/therapeutic agents
IPC: A61K/
Filed: 1999-04-22
Abstract: Novel membrane-forming amphiphilic lipopeptides comprising one or more peptide moieties containing 2-50 aminoacyl residues and one or more hydrocarbon chains containing 5-50 carbon atoms. Such lipopeptides may be used in the formation of stabilised gas microbubble dispersions suitable for use as diagnostic and/or therapeutic agents, for example as ultrasound contrast agents.
Patent IL-139950-A0 (IL)
Title: Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
IPC: A61P35/00
Filed: 1999-06-04
Abstract: A complex comprising an HLA Class 1 molecule and attaching means for selectively attaching the HLA class 1 molecule to a target cell is disclosed, and a method is provided for producing or enhancing an immunological response against a target cell, by attaching said complex to the target cell. Where the target is a diseased, foreign or malignant cell, this method may be used to promote the lysis of the targeted cell by T cells in the immune system. Where the target cell is an antigen presenting cell, this method may be used to promote the proliferation of specific T cell clones. The invention is of potential use in the prevention and treatment of malignant diseases including cancer and leukemia, infectious diseases including viral infections such as HIV, bacterial infections including tuberculosis, and parasitic infections including malaria.
Patent IL-140661-A0 (IL)
Title: Turbo interleaving apparatus and method
IPC: H03M13/29
Filed: 2000-05-19
Abstract: A 2-dimensional interleaving method is disclosed. The method comprises dividing a frame of input information bits into a plurality of groups and sequentially storing the divided groups in a memory; permuting the information bits of the groups according to a given rule and shifting an information bit existing at the last position of the last group to a position preceding the last position; and selecting the groups according to a predetermined order, and selecting one of the information bits in the selected group. <IMAGE>
Patent IL-147803-A0 (IL)
Title: 28-epirapalogs
IPC: C12N15/12
Filed: 2000-08-24
Abstract: Methods and materials involving 28-epirapamycin analogs are disclosed.
Patent IL-159322-A0 (IL)
Title: A piezoelectric actuator
IPC: G02B6/32
Filed: 2002-06-19
Abstract: An actuator comprises a laminate of interleaved layers of electrode plates and piezoelectric material; wherein an upper region (in use) of electrode plates is adapted when energized to effect deflections in up and down directions; a lower region of electrode plates is adapted when energized to effect deflections in up and down directions; and one or more further regions of electrode plates are adapted when energized to effect deflections in left and right directions.
Patent IL-176278-A0 (IL)
Title: Adjustable sprinkler nozzle
IPC: B05C17/005
Filed: 2006-06-13
Abstract: Sprinkler nozzle which is formed of two parts which each mesh into each other with one of their far ends and which are mutually connected by means of a snap system which makes it possible to lock both parts in different positions in relation to each other, whereby the first part ( 2 ) consists of a hollow body with a passage ( 5 ) which is or can be fixed to a spray cylinder ( 1 ), and whereby the second part ( 4 ) consists of a hollow body in which is provided a die channel ( 6 ), characterised in that the above-mentioned snap system is formed of two contact surfaces working in conjunction with each other, one of which is part of the first part ( 2 ) and consists of a multi-surfaced edge ( 9, 10, 11 ), and the other contact surface of which is part of the second part ( 4 ) and consists of a multi-surfaced ring ( 13, 14, 15 ) which is complementary to the above-mentioned multi-surfaced edge ( 9, 10, 11 ).
Patent IL-194988-A0 (IL)
Title: Security enhanced print media with copy protection
Filed: 2008-10-30
Abstract: Copy protections are incorporated into print media by embedding a plurality of latent images formed by different line-screen patterns within a visually integrated setting formed by another different line-screen pattern. The different line-screen patterns of the latent images have line frequencies empirically selected so that upon reproduction at least one of the latent images is rendered more readily discernable to the unaided eye. A masking design formed by another line-screen pattern overlies both the latent images and the visually integrated setting.
Patent IL-214431-A0 (IL)
Title: Taxane derivatives functionalized at the 14-position and a process for the preparation thereof
IPC: C07D305/14
Filed: 2011-08-03
Abstract: A process for the preparation of compounds of formula XIV starting from compounds of formula XIII   
wherein 
R 2  is an acyl group or an alcohol-protecting group; 
R 3  is hydrogen, acyl, alkyl or, taken together with R 4 , forms a C=O, C=S, SO, SO 2  group; 
R 4  is hydrogen or, taken together with R 3 , forms a C=O, C=S, SO, SO 2  group; 
R 5  is hydrogen or an alcohol-protecting group; 
R 6  is aryl, substituted aryl, heteroaryl; 
comprising: 
a) selective reduction of the azido group to amino group; 
b) optional treatment with alkylating or acylating agents; 
c) cleavage of the C7 protective group; 
d) opening of the oxazolidine.
Patent RO-126521-A0 (RO)
Title: Method for quantitatively evaluating the eyeground lesions on the black-and-white photos
Inventor: IANOPOL VASILICA NARCISA
IPC: A61B3/12
Filed: 2010-08-19
Abstract: The invention relates to a method for quantitatively evaluating eyeground lesions on black-and-white photos recorded digitally in various types of investigations used in ophthalmology. According to the invention, the method consists in measuring the area of the lesions of interest expressed in black or white pixels, colour conventionally established depending on the type of lesion, on black-and-white photos carried out in pre-established lighting, image focusing, pupil dilating, environment obscurity and processed subsequently for regulating the grey tones at a saturation level of up to 50% pure white and over 50% pure black, the measurements being performed within some established regions depending on the aspect of the lesions of interest in the shape of a circle circumscribed to the lesion, tangent or concentric to another circle circumscribed to the optical nerve head, the final results being corrected by the application of a factor for the correction of the variation of the incidence angle under which the photos are recorded in successive examinations.
Patent RO-126160-A0 (RO)
Title: Method for preparing a scintillating material and scintillating material obtained thereby
Inventor: POLOSAN SILVIU
IPC: G01T1/29
Filed: 2010-10-20
Abstract: The invention relates to a scintillating material of the BiGeOceramic glass type with adequate properties to be used as X-ray detector, electron detector and in the field of nuclear physics at low energy levels, below 20 keV. According to the invention, the method consists in mixing BiOand GeO, in a molar ratio of 2:3, in a mortar, in the presence of acetone, eliminating the acetone by heating the mixture to a temperature of 100°C up to drying, introducing the dry mixture into a ceramic crucible and heating the same up to a temperature ranging between 700...750°C, for 10...24 h, to achieve the solid phase reaction between the oxides, the mixture is homogenized again and there is checked by means of X rays whether the reaction is completed, then the mixture is remelted at the temperature of 1050°C, for 5...10 min, and, further on, is overcooled on a graphite plate down to a temperature of more than 250°C, after which the mixture is left to cool naturally down to the ambient temperature, the resulting material being finally recrystallized by heating it up to a temperature of 560...800°C to obtain a transparency of 48...50%.
Patent RO-129373-A0 (RO)
Title: Process for producing zinc oxide fibres with submicronic diameters by electrospinning, using polymethyl methacrylate solution
Inventor: EVANGHELIDIS ALEXANDRU IONUŢ
IPC: D01D5/00
Filed: 2013-11-22
Abstract: The invention relates to a process for producing zinc oxide fibres by electrospinning from polymethyl methacrylate solutions in dimethylformamide, the fibers being used in the field of optoelectronics, in order to manufacture transparent electrodes to be used in photovoltaic devices, comprised within gas sensors and the like. The claimed process takes place in an environment with t=22°C and relative humidity of 70% and consists in preparing a working solution comprising 10% polymethyl methacrylate with a molecular mass of 350000, 7.5% Zn acetate and dimethylformamide as solvent, which is introduced into a syringe fixed in a syringe pump having as spinneret a stainless steel needle with an inside diameter of 0.5 mm, which is connected to a high voltage source of 15 kV and supplied with a polymer solution with a rate of 0.5 ml/h, the unstable solution jet being projected towards a panel-type collector connected to the ground, after which the collector is subjected to a calcining heat treatment consisting of two stages: a first slow heating in air by 2°C/min up to reaching a calcining plateau of 450°C, while maintaining said plateau for 1 h, and a second heating by 5°C/min up to reaching a calcining plateau of 800°C which is maintained for 8 h.
Patent RO-131054-A0 (RO)
Title: Friction-damping energy absorber
Inventor: MR CHONG-SHIEN TSAI
IPC: F16F15/04
Filed: 2015-12-14
Abstract: The invention relates to a friction-damping energy absorber used in buildings, bridges and other large objects, facilities or equipments, to absorb and isolate the vibration energy of the earthquake and of the environment and which can prevent the operational temperature increase and provide a function of automatic regulation and adaptative characteristics of damping and rigidity, in order to perform separately the optimal functions for multiple performance objectives at the multiple vibration level. According to the invention, the friction-damping energy absorber has at least one central pole (10), two support plates (20), some layers (30) of a first material and some multiple layers (40) of a second material, at least one central pole (10) having multiple sliding sheets (11), stacked on top of one another, where the two support plates (20) may be mounted on the two ends of at least one central pole (10), the layers (30) of the first material and the layers (40) of the second material being alternately mounted between two support plates (20) and surrounding at least one central pole (10) to allow the layers (30) of the first material and the layers (40) of the second material to be alternately mounted with at least one of the sliding sheets (11) of at least one central pole (10).